EWSR1 immunotherapy: Clinical Trials

1 trial of EWSR1 immunotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1

Follow EWSR1 immunotherapy: new trials by email Literature Review of EWSR1 immunotherapy trials Research Report on EWSR1 immunotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT
EWSR1 immunotherapy, Pembrolizumab - Ewing Sarcoma, Desmoplastic Small Round Cell Tumor
Phase 1Not yet recruitingRabi Hanna242026-10-012026-09-17

Conditions studied

Desmoplastic Small Round Cell Tumor (1)  ·  Sarcoma, Ewing (1)

Sponsors

Rabi Hanna (1)

Countries

United States (1)

Top investigators

Matteo Trucco, MD (1)  ·  Peter M Anderson, MD, PhD (1)  ·  Rabi Hanna, MD (1)  ·  Timothy A Chan, MD, PhD (1)